U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents (LLY)

Eli Lilly and Company LLY today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista are valid. These patents provide protection for Evista in the U.S. through March of 2014. Click here to get today's best trading ideas.